ArticleClinical and translational science2021

Population pharmacokinetic and exposure-response analyses of ivosidenib in patients with IDH1-mutant advanced hematologic malignancies.

Xuemin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.